Population-targeted RCT (12 weeks) A multicenter clinical study involving 90 women aged 3350 years evaluated 500 mg/day of oral glutathione over 12 weeks
Helps reduce stress and anxiety
Accelerated recovery
Disease modifying agents capable of controlling obesity with meaningful metabolic improvement have reshaped expectations for both clinicians and patients ( Nausea and vomiting remain among the most frequent and disruptive adverse effects across Glucagon-like peptide (GLP-1)-based therapies ( In this opinion article, we examine the mechanisms underlying nausea and vomiting in semaglutide, CagriSema, survodutide, tirzepatide, retatrutide, and orforglipron and situate them within obesity clinical practice ( We also propose practical strategies to mitigate gastrointestinal intolerance
Common signs include tiredness, memory issues, pale skin, mood changes, and tingling in the hands or feet
Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture